Patents expiring in 2031

US 8017636

1,2,4-Oxadiazole benzoic acid compositions and their use in bioassays

PTC THERAPEUTICS, INC. · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017617

Amidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017578

Orally active peptides that prevent cell damage and death

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017155

Methods for encapsulation of biomacromolecules in polymers

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017321

Gefitinib sensitivity-related gene expression and products and methods related thereto

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017149

Modified release preparations containing oxcarbazepine and derivatives thereof

Supernus Pharmaceuticals, Inc. · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017151

Amphiphilic polymer-protein conjugates and methods of use thereof

Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017130

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017135

Lipid-drug conjugates for local therapy of eye diseases

The Regents of the University of California · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017619

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8017763

Chemically modified oligonucleotides

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022057

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022094

Carvedilol phosphate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022190

Immuno-molecules containing viral proteins, compositions thereof and methods of using

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021687

Modified release compositions of milnacipran

Collegium Pharmaceutical, Inc. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021831

Taxane chemosensitivity prediction test

The Board of Regents of the University of Texas System · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022041

Prodrug of an ICE inhibitor

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022175

Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022202

Dihydrodiazepines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021673

Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

The Regents of the University of California · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021644

Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis

The Regents of the University of California · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021646

Compositions and methods for magnetic resonance imaging contrast agents

Northwestern University · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021671

Pro-apoptotic bacterial vaccines to enhance cellular immune responses

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021874

Very long chain polyunsaturated fatty acids, methods of production, and uses

The Board of Regents of the University of Oklahoma · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022040

Hydroxyapatite-binding peptides for bone growth and inhibition

The Regents of the University of California · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8022052

Inhibition of PPAR gamma expression by specific osteogenic oxysterols

The Regents of the University of California · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026350

Tumor suppressor gene, p28ING5

The United States of America as represented by theDepartment of Health and Human Services · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026263

Methods for inhibiting neoproliferative changes in blood vessel walls

The Regents of the University of California · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8025887

Avirulent, immunogenic flavivirus chimeras

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8025891

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026234

Polo-like kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026360

Substituted pyridazines as stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026284

Enterically coated cystamine, cysteamine and derivatives thereof

The Regents of the University of California · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026226

Medical and nutritional applications of highly refined cellulose

Regents of the University of Minnesota · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8026347

Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

LEXICON PHARMACEUTICALS, INC. · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030010

Method for detecting a biomarker of oxidative stress in a biological sample

INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030502

Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

Theravance, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030483

Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030447

Substrate peptide sequences for plague plasminogen activator and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030337

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030341

Dmt-derivative compounds and related compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030331

Allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030317

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030307

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030333

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030280

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030070

Artificial lymphoid tissue equivalent

SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030012

Id-1 and Id-2 genes and products as markers of epithelial cancer

The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)